These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10111726)

  • 61. Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections.
    Portolés A; Palau E; Puerro M; Vargas E; Picazo JJ
    Rev Esp Quimioter; 2006 Mar; 19(1):65-75. PubMed ID: 16688294
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An aminoglycoside monitoring service in a community hospital using a microcomputer.
    Voytovich RM; Outten RL
    Hosp Pharm; 1987 Mar; 22(3):267-72. PubMed ID: 10281372
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Appropriate but not cost effective ceftazidime use in a university hospital.
    Colburn PA; Carver PA; Montgomery PA; Alaniz C; Chaffee BW; Amesbury BK
    Hosp Pharm; 1989 Nov; 24(11):911-6, 928. PubMed ID: 10313376
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of a vancomycin restriction policy on use and cost of vancomycin and incidence of vancomycin-resistant Enterococcus.
    Morgan AS; Brennan PJ; Fishman NO
    Ann Pharmacother; 1997 Sep; 31(9):970-3. PubMed ID: 9296233
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The prevalence of suspected and challenge-verified penicillin allergy in a university hospital population.
    Borch JE; Andersen KE; Bindslev-Jensen C
    Basic Clin Pharmacol Toxicol; 2006 Apr; 98(4):357-62. PubMed ID: 16623858
    [TBL] [Abstract][Full Text] [Related]  

  • 66. How pharmaceutical controls worked in one Ontario hospital.
    McLean WM; Tierney MG
    Can J Hosp Pharm; 1994 Aug; 47(4):176-9. PubMed ID: 10136951
    [No Abstract]   [Full Text] [Related]  

  • 67. Medication use and potential drug interactions in pediatric patients with infectious diseases.
    Lisby SM; Nahata MC
    Hosp Pharm; 1987 Apr; 22(4):354, 356. PubMed ID: 10281735
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A cost containment tool for antibiotics.
    Judd C; Moist L; Rose C; Gopaul D
    Dimens Health Serv; 1989 Nov; 66(8):25-6. PubMed ID: 2606294
    [No Abstract]   [Full Text] [Related]  

  • 69. The effect of an education program on cefazolin prescribing.
    Blain L; O'Brodovich M
    Can J Hosp Pharm; 1989 Apr; 42(2):69-71. PubMed ID: 10292923
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Developing and implementing a model for changing physicians' prescribing habits-- the role of clinical pharmacy in leading the change.
    Schwartzberg E; Rubinovich S; Hassin D; Haspel J; Ben-Moshe A; Oren M; Shani S
    J Clin Pharm Ther; 2006 Apr; 31(2):179-85. PubMed ID: 16635053
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cost containment through therapeutic substitution of aminoglycosides.
    Guernsey BG; Berina LF; Lazarus MC; Hokanson JA; Prohaska C; Allen JA; Doutre WH; Mader JT
    Hosp Pharm; 1985 Feb; 20(2):82-3, 86-92, 95. PubMed ID: 10270312
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The cost-effectiveness of clinical pharmacist intervention on tobramycin prescribing.
    Khanderia U
    Hosp Formul; 1986 Oct; 21(10):1049-50, 1055-6. PubMed ID: 10311722
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Strategies to improve antibiotic use.
    Bryan CS
    Infect Dis Clin North Am; 1989 Dec; 3(4):723-34. PubMed ID: 2687360
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cost containment through restriction of cephalosporins.
    Britton HL; Schwinghammer TL; Romano MJ
    Am J Hosp Pharm; 1981 Dec; 38(12):1897-900. PubMed ID: 7325168
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Audit of phenytoin prescribing for outpatients.
    Curry CE; Antal EG; Keys PW; Duffy MG
    Am J Hosp Pharm; 1981 Aug; 38(8):1158-60. PubMed ID: 7270560
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Containing pharmacy costs requires careful review, cooperation.
    Roark M
    Healthtexas; 1990 Oct; 46(5):14-5. PubMed ID: 10113346
    [No Abstract]   [Full Text] [Related]  

  • 77. Efficacy and cost-containment in hospital pharmacotherapy: state of the art and future directions.
    Soumerai SB; Avorn J
    Milbank Mem Fund Q Health Soc; 1984; 62(3):447-74. PubMed ID: 6433223
    [No Abstract]   [Full Text] [Related]  

  • 78. Pharmacy: computerless drug use review.
    Deliganis SG; Johnson SR
    Hospitals; 1973 Dec; 47(23):86 passim. PubMed ID: 4761628
    [No Abstract]   [Full Text] [Related]  

  • 79. Improving the appropriateness of vancomycin use by sequential interventions.
    Lipsky BA; Baker CA; McDonald LL; Suzuki NT
    Am J Infect Control; 1999 Apr; 27(2):84-91. PubMed ID: 10196484
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Consultant pharmacists to assist with cost-containment and enhanced drug use management.
    Payne L; Crone K; Pilla J
    Can J Hosp Pharm; 1990 Oct; 43(5):247-8. PubMed ID: 10107927
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.